NCT05020522View on ClinicalTrials.gov

Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

702

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2025

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Luminal Index MRI (LI-MRI)

Multiecho T2 sequence; eventual biopsy of lesion(s) detected with LI-MRI only.

DIAGNOSTIC_TEST

LI-MRI targeted prostate biopsy

Biopsy targeted to suspicious lesions detected with LI-MRI only

DIAGNOSTIC_TEST

Plasma methylation signature (ctMethSig)

Blood sample.

Trial Locations (1)

Unknown

RECRUITING

University College London Hospitals NHS Foundation Trust, London

All Listed Sponsors
lead

University College, London

OTHER